Why Leveraged ETFs Decay — The Math Behind the 80% Loss
 | |||||||||||||||
Two ETFs track the same underlying index. Over six months, the underlying climbs back to where it started — flat, on net. One ETF is up zero percent. The other is down thirty. Both are doing exactly what they were built to do. This is volatility decay, and it is the quietest predator in the retail ETF lineup. The 2x leveraged ETF, the 3x leveraged ETF, the inverse ETF — they all share one structural feature: they reset their leverage every trading day. That daily reset is the entire problem. It is not a flaw. It is the design. Here is the simple math. Suppose an underlying index sits at 100. Monday it falls 10% to 90. Tuesday it rises 11.1% back to 100. The underlying is flat over the two days. Now apply 2x daily leverage. Monday, the 2x ETF falls 20% from 100 to 80. Tuesday, it rises 22.2% from 80 to 97.78. The underlying is back at 100. The 2x ETF is at 97.78. Over a flat two-day stretch, the leveraged product lost 2.2%. Apply 3x leverage to the same sequence. Monday, −30% (100 → 70). Tuesday, +33.3% (70 → 93.3). Same flat two days. The 3x product is down 6.7% — three times the bleed of the 2x. And outside the United States, the leverage ratios climb higher still. The United Kingdom and European exchanges offer 5x leveraged ETPs on commodities, indices, and individual stocks. Each additional turn multiplies the same decay. The retail traders who buy them are usually the ones who wanted bigger wins. They get bigger volatility decay instead. Stretch this across hundreds of trading days. Every up-down pair leaks a little value. Every choppy week takes another bite. The underlying can finish a year exactly where it started, and a 2x ETF tracking it can be down anywhere from 15% to 30% over the same stretch — depending on how rough the path was. This is path dependency, and it is the part nobody explains at the brokerage onboarding screen. The Trade I Made, and the Week I Held ItYou may have bought a 2x or 3x ETF because you were sure about the direction. Most retail buyers of these products are. I have been one of them, more than once, and one of those times was this year. Early in 2026, sugar was collapsing. World raw sugar futures had fallen from 27.31 cents a pound in November 2025 to a five-year low of 13.34 cents by mid-February, on a projected global surplus of roughly 2.9 million tonnes and falling energy prices that pushed cane mills toward sugar and away from ethanol. My thinking was not complicated, and I still think the mechanism is real. Prices that low do not just sit there. Growers stop planting. Marginal mills stop running. Supply contracts, and eventually the price has to answer. Supply destruction is one of the oldest arguments in commodities. So I bought a leveraged sugar product listed in London. I held it for one week and got out. Not because I stopped believing the argument. Because I watched what the daily reset was doing to the position while sugar chopped sideways, and I understood that the mechanism I was betting on runs on a farmer's calendar — seasons, planting decisions, mill economics — and the product I had bought runs on a trading day. Those two clocks are not compatible. One of them was going to finish first, and it was not the farmer. Sugar has since traded in a narrow band between roughly 13 and 16 cents for the rest of the year. The rally I was waiting for has not arrived. It may still. But the position that was supposed to capture it would have bled out months before it got here, and that is the entire point of this post. I was not wrong about sugar. I was wrong about the instrument. How Fast Does It Actually Bleed?There is a rough formula for this, and almost no retail article prints it. The annual drag from volatility decay is approximately ½ × L × (L−1) × σ², where L is the leverage multiple and σ is the annualized volatility of the underlying. It is an approximation, and it breaks down at extreme volatility, but it is close enough to plan with.
Read the bottom row again. At crypto-level volatility, a 3x product does not merely underperform. It approaches a structure where a flat year still ends near zero. Notice also what the table does not depend on: direction. None of these numbers assume the underlying fell. This is the cost of a flat year. The Case That Shows It BestThe most public 2026 example is XRP. As of April 2026, the spot token was down roughly 61% from its July 2025 all-time high of $3.66. The Teucrium 2x Long Daily XRP ETF was down roughly 94% from its own peak of $68.88 over the same window. That gap — more than thirty percentage points in twelve months, on a product that promised twice the move — is volatility decay made visible. Now here is the part that is easy to miss, and it happened after the numbers above. On June 26, 2026, Teucrium announced a 1-for-10 reverse split of that fund. Every ten shares became one. Split-adjusted trading began June 29, and the share price on the chart multiplied by ten overnight. Nothing was recovered. Not one dollar came back to anyone holding it. The fund simply changed the unit it reports in, and the chart stopped showing what had happened. This is worth knowing before you buy any leveraged product, because it is common and it is quiet. A reverse split is what these funds do when the decay has run so far that the share price becomes an embarrassment — a few dollars, sometimes less. The split resets the visual record while leaving the loss exactly where it was. A newcomer pulling up the chart afterward sees a respectable-looking price and a short history. If you ever find yourself looking at a leveraged ETF whose chart seems suspiciously clean, check the fund's split history before you check anything else. The same story has played out before, without the split to hide it. MicroStrategy's 2x products lost a large fraction of their value during 2024–25 chop, even as the underlying eventually recovered. Direxion's 3x semiconductor ETF (SOXL) requires a steady, roaring uptrend to outperform; sideways or volatile years are punishing. ProShares' 3x QQQ (TQQQ) survives clean bull runs and is decimated in choppy bear markets. Inverse Products Carry One Extra ProblemInverse ETFs share the same disease — with an additional risk during extreme-volatility days. When the underlying moves so violently that exchanges trigger a brief trading halt, the inverse product can re-price at a level that does not match the underlying's eventual round trip. Round trip on the underlying does not mean round trip on the inverse. SQQQ, SOXS, every -1x, -2x, and -3x product carries that asymmetry. I know that one from the other side. In January of this year I held a 2x inverse silver position through a two-week stretch that took it down nearly forty percent, and then watched a single-day collapse in silver hand the whole loss back and put me in profit. I wrote about that trade here, including the part where the recovery taught me the wrong lesson. The relevant detail for this post is narrower. I was not rescued by being right. I was rescued by a single violent day landing on the correct side of my position. On a product that resets every morning, that is what the outcome depends on — not on whether the thesis eventually proves out. The daily reset works against these products in any market that is not moving steadily in one direction, and works against them violently in markets that whipsaw. Before You Buy OneLeverage and inverse ETFs are not buy-and-hold instruments. They were designed for traders with a one-day to one-week horizon and a directional thesis. A retail investor holding one for six months in a sideways market is not on the trade the product was built for. One. The product resets daily. Your one-month return will not be 2x the underlying's one-month return. It will be 2x of each individual day's return, compounded — and the compounding through volatility leaks value. Two. The longer you hold, the more volatility eats. Holding through a noisy quarter is more expensive than holding through a smooth one. There is no fee line for this on the prospectus, but there is a math line. Three. Check the split history. A clean-looking chart on a leveraged product often means the record was reset, not that the product performed. Four. Match the clock. Ask how long your thesis needs to play out — weeks, seasons, years — and compare that to a product that rebalances every afternoon. If your reason is slower than the instrument, the instrument will finish first. Five. The underlying name itself, with no leverage, is the safer way to be wrong about direction. Buffett’s most quoted rule is never lose money, and this is one of the cleanest ways retail breaks it. Most investors who blew up on leveraged ETFs did not lack conviction. They had too much of it, channeled into a product that mathematically punished long holding. The cure is not better timing. The cure is owning the underlying name itself, sized small enough that being wrong is permitted. If you find yourself reaching for a 2x or 3x because the underlying should go up, the position size on the underlying is the variable to adjust — not the leverage. And if you take one thing from the sugar story: I still do not know whether I was right. The instrument made sure I would never find out. |
Sugar futures figures per ICE #11 world raw sugar contract data and StoneX surplus projections, 2026. XRP and Teucrium XXRP performance figures as of April 2026, per CoinDesk, Yahoo Finance, and Decrypt; the 1-for-10 reverse split effective June 29, 2026 per Teucrium's own announcement of June 26, 2026. MicroStrategy 2x ETF performance per public ETF.com listings. Volatility decay mechanics are standard finance literature; ProShares and Direxion publish educational materials confirming the daily-reset structure. Readers should verify current ETF figures with issuer NAV pages before any trading decision.
Related Posts:
The Silver Trade That Got Lucky — and Taught Me the Wrong Lesson
How to Know If Your Position Is Too Big — The Sunday Night Test
The Year Your Portfolio Is Down 30% — A Behavior Guide
The Rule of 72: How to Know When Your Money Doubles
